Unapologetic Living with Elizabeth Elliott Microbes Matter with Martha Carlin, Founder of Biotiquest
by Martha Carlin August 19, 2024
Martha Carlin is a transformational leader who has leveraged her extensive business experience as a turnaround expert to become a leading citizen scientist in the field of the microbiome. With a focus on improving human health, Carlin founded The BioCollective, a company dedicated to studying the microbiome and its impact on human health. Through The BioCollective, she has conducted groundbreaking research on the gut microbiome and its relationship to diseases such as Parkinson's. Carlin also launched the BiotiQuest brand of targeted probiotics, which offers targeted probiotics to restore lost microbiome function and restore balance. Her innovative approach has earned recognition from the National Institutes of Health and the White House Microbiome Initiative, making her a key figure in the field of microbiome research.
Behind closed eyes, the brain is carrying out a carefully coordinated night shift. And research into the microbiome raises an intriguing question: how might the activity in our gut influence the sleep that gives this work its opportunity?
When discussing gut health, the conversation usually centers on the microbiome. While balancing gut bacteria remains essential, cutting-edge science highlights another critical component of cellular health: the glycocalyx.
When discussing chronic neurological conditions like Parkinson’s disease, conventional medicine frequently focuses on a single narrative: dopamine depletion. While managing neurotransmitters remains a core part of traditional care, emerging physical chemistry and microbiome research reveal a far broader picture.